# 510 (k) Summary

In accordance with the requirements of SMDA 1990, and 21 CFR 807.92, this 510(k) Summary is provided:

1.

Submitted by:

AgaMatrix, Inc.

230 Albany Street

Cambridge, MA 02139

Contact Person: Connie Hertel Director Quality & Regulatory Affairs Phone: (617) 252- 6529 x25 Fax: (617) 588 - 0430

Date Prepared: 23 September 2005

# 2. Device Name:

Trade/Proprietary Name:   
Common/Usual Name:   
Classification Name:   
Class:   
Panel:   
Liberty™ Blood Glucose Monitoring System   
Blood Glucose Monitoring System   
Glucose test system (per 21 CFR 862.1345)   
II   
Chemistry

3. Predicate Device:

The Liberty' Blood Glucose Monitoring System is substantially equivalent to the Ascensia Contour Blood Glucose Monitoring System, cleared under K023657.

# 4. Description of the Device

The AgaMatrix Liberty Blood Glucose Monitoring System includes a meter with batteries, compact carrying case, quick start guide, reference guide, owner's booklet, and warranty/registration card. Test Strips, Lancing device, Lancets, and Control Solution are purchased separately.

It is intended for over-the-counter home use by diabetics to monitor their blood glucose levels, or for use in a clinical setting by healthcare professionals. The system tests fresh capillary whole blood. The meter is a portable, battery-operated instrument.

# 510(k) Summary (Continued)

# 5. Intended use of the Device

The Liberty Blood Glucose Monitoring System is intended to quantitatively measure blood glucose levels, also known as blood sugar, from fresh capillary whole blood samples taken from the fingertips or the palm. The Liberty™ Test Strips are for in vitro diagnostic (outside of the body) use only. The Liberty™ System is not intended for use with neonates.

# 6. Summary of the technological characteristics of the device compared to the predicate device

The Liberty Blood Glucose Monitoring System has similar materials and basic design. The new device contains additional features compared to the predicate device. These additional features include faster test time, smaller sample size, and better accuracy.

# 7. Testing

The manufacturer of the Liberty™ Blood Glucose Monitoring System certifies that its device complies with the following:

ISO 15197:2003 In ritro diagnostic test systems - Requirements for bloodglucose monitoring systems for self-testing in managing diabetes mellitus

ISO 14971:2000 Medical devices - Application of risk management to medical devices

IEC 61010-1 Medical electrical equipment - General requirements for safety

IEC 61010-2-101 Safety requirements for electrical equipment for measurement, control and laboratory use - particular requirements for in vitro diagnostic (IVD) medical equipment

IEC 61000-4-3 Electromagnetic compatibility (EMC)

# Conclusions

Based upon the testing and comparison to the predicate device, the Liberty Blood Glucose Monitoring System has the same intended uses, with similar technological characteristics as the predicate device. The system performs as intended and raises no new safety of effectiveness issues.

# JAN 2 3 2006

Ms. Connie Hertel   
Director Quality & Regulatory Affairs AgaMatrix Inc.   
230 Albany Street   
Cambridge, MA 02139

Re: k052762 Trade/Device Name: AgaMatrix LibertyTM Blood Glucose Monitoring System Regulation Number: 21 CFR $\ S 8 6 2 . 1 3 4 5$ Regulation Name: Glucose test system Regulatory Class: Class II Product Code: NBW, CGA, JJX Dated: December 22, 2005 Received: January 10, 2006

Dear: Ms. Hertel:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devies that have beerlassin cordance with the provisions theFederal FodDr, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or classIII (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2 -

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0484. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address   
http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

![](images/3a1f9b946b3e97eac62af6bcbe509ba33d219a318ed4e33d16056fbf4b2827d7.jpg)

Alberto Gutierez, Ph.D.   
Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device Evaluation and Safety   
Center for Devices and Radiological Health

# Indications for Use

510(k) Number: K052762

Device Name: AgaMatrix Liberty™ Blood Glucose Monitoring System

Indications For Use:

AgaMatrix Liberty™ Blood Glucose Monitoring System:

AgaMatrix Liberty™ Blood Glucose Monitoring System is intended for the quantitative measurement of glucose in fresh capillary whole blood from thefingertip and palm of the hand Testing is doneoutsie the body (in vitro diagnostic use). It is indicated for use at home (over the counter (OTC) ) by persons with diabetes,  n a cinicl settigbhealthcare professionals, as an id tmonitorhe effectiveness  dbee control.

# AgaMatrix Liberty™ Blood Glucose Meter:

AgaMatrix Liberty™ Blood Glucose Meter is intended for use with AgaMatrix Liberty'Blood Glucose Test Strips for the quantiativemeasurement  gucose nfresh capillary whole lood from the ngerti and pal  the handTetng is doneutside the body n vio digostic use. It iindcated oruseat ome (ov the counter (OTC)) by persns with diabetes, or in a clinical settin by healthcare professionals, as an aid to monitor the effectiveness of diabetes control.

# AgaMatrix LibertyBlood Glucose Test Strips:

AgaMatrix Liberty Blood Glucose Test Strips are intended for use with AgaMatrix Liberty'Blood Glucose Meter for the quantitative measurement of glucose in fresh capillary whole blod from the fingertip and palm of the hand.Testing is doneoutside the body (invitro diagnostic use). It is indicated or ue at home (over the counter OTC) ) by persons wit diabetes, orn a clinical settin by healthcare professnals, as an aid to monitor the effectiveness of diabetes control.

# AgaMatrix Liberty™M Control Solutions (Normal level and High level):

AgaMatrix Liberty Control Solutions are intended for use with the AgaMatrix Liberty' Meter and results.